Novartis opens new cell and gene therapies facility in Switzerland

This article was originally published here

The new facility also facilitates the production of advanced and difficult-to-manufacture solid dosage forms such as tablets and capsules, in addition to the manufacturing of novel CAR-T cell

The post Novartis opens new cell and gene therapies facility in Switzerland appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply